Advanced 4th generation assays for earlier diagnosis
The VIDAS® HIV panel provides a combination of advanced 4th generation assays for improved detection of acute HIV during the critical “window period”.
Combined detection of anti-HIV-1 (groups M and O) and anti-HIV-2 total immunoglobulins + HIV-1 p24 antigen
True dual information: differentiation of Ag and Ab signals
Highest p24 Ag sensitivity currently available
Many of the 35.3 million people infected with HIV worldwide are unaware of their condition, as symptoms may be absent or non-specific. In addition, there is a mean period of 3 weeks between contamination and the appearance of the first anti-HIV serum antibodies1. Early detection of seroconversions is thus one of the main HIV diagnostic challenges.
The VIDAS® automated HIV infection screening tests allow simultaneous detection of p24 antigen and anti-HIV antibodies enabling the time lapse between contamination and diagnosis of the infection to be decreased. Identifying more primary infections can make a key difference in reducing transmission. Providing appropriate therapy as fast as possible is also essential to improve patient outcome.